The effect of hyperbaric oxygen on human oral cancer cells

Undersea and Hyperbaric Medicine

Volumn 31, Issue 2, 2004, Pages 251-260

  Sun, T B ^a   Chen, R L ^a   Hsu, Y H ^a  

^a TZU CHI UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; DNA FRAGMENT;

ANIMAL; APOPTOSIS; ARTICLE; BODY WEIGHT; CANCER TRANSPLANTATION; GENETICS; HUMAN; HYPERBARIC OXYGEN; MALE; METHODOLOGY; MOUSE; MOUSE MUTANT; MOUTH TUMOR; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; BODY WEIGHT; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DNA FRAGMENTATION; HUMANS; HYPERBARIC OXYGENATION; MALE; MICE; MICE, SCID; MOUTH NEOPLASMS; NEOPLASM TRANSPLANTATION; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 4544322850     PISSN: 10662936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Marx RE. A new concept in the treatment of osteoradionecrosis. J Oral Maxillofac Surg 1983; 41: 351-357.
2. Marx RE, Johnson RP. Studies in the radiobiology of osteoradionecrosis and their clinical significance. Oral Surg Oral Med Oral Pathol 1987; 64: 379-390.
3. Feldmeier JJ, Heimbach RD, Davolt DA, McDonough MJ, Stegmann BJ, Sheffield PJ. Hyperbaric oxygen in the treatment of delayed radiation injuries of the extremities. Undersea Hyperb Med 2000; 27: 15-19.
4. Feldmeier JJ, Hampson NB. A systematic review of the literature reporting the application of hyperbaric oxygen prevention and treatment of delayed radiation injuries: an evidence based approach. Undersea Hyperb Med 2002; 29: 4-30.
5. Zamboni WA, Roth AC, Russell RC, Graham B, Suchy H, Kucan JO. Morphologic analysis of the microcirculation during reperfusion of ischemic skeletal muscle and the effect of hyperbaric oxygen. Plast Reconstr Surg 1993; 91: 1110-1123.
6. Mink RB, Dutka AJ. Hyperbaric oxygen after global cerebral ischemia in rabbits does not promote brain lipid peroxidation. Crit Care Med 1995; 23: 1398-1404.
7. Tibbies PM, Edelsberg JS. Hyperbaric-oxygen therapy. N Eng J Med 1996; 334: 1642-1648.
8. Thom SR, Mendiguren I, Hardy K, Bolotin T, Fisher D, Nebolon M, Kilpatrick L. Inhibition of human neutrophil beta2-integrin-dependent adherence by hyperbaric O2. Am J Physiol 1997; 272: C770-C777.
9. Zamboni WA, Stephenson LL, Roth AC, Suchy H, Russell RC. Ischemia-reperfusion injury in skeletal muscle: CD 18-dependent neutrophil-endothelial adhesion and arteriolar vasoconstriction. Plast Reconstr Surg 1997; 99: 2002-2007.
10. Buras JA, Stahl GL, Svoboda KK, Reenstra WR. Hyperbaric oxygen downregulates ICAM-1 expression induced by hypoxia and hypoglycemia: the role of NOS. Am J Physiol - Cell Physiol 2000; 278: C292-C302.
11. Feldmeier JJ, Heimbach RD, Davolt DA, Brakora MJ, Sheffield PJ, Porter AT. Does hyperbaric oxygen have a cancer-causing or -promoting effect? A review of the pertinent literature. Undersea Hyperb Med 1994; 21: 467-475.
12. Jain KK. Textbook of hyperbaric medicine. 3rd rev. ed. Gottingen: Hogrefe and Huber publisher, 1999.
13. McMillan T, Calhoun KH, Mader JT, Stiernberg CM, Rajaraman S. The effect of hyperbaric oxygen therapy of oral mucosal carcinoma. Laryngoscope 1989; 99: 241-244.
14. Headley DB, Gapany M, Dawson DE, Kruse GD, Robinson RA, McCabe BF. The effect of hyperbaric oxygen on growth of human squamous cell carcinoma xenografts. Arch Otolaryngol - Head Neck Surg 1991; 117: 1269-1272.
15. Sklizovic D, Sanger JR, Kindwall EP, Fink JG, Grunert BK, Campbell BH. Hyperbaric oxygen therapy and squamous cell carcinoma cell line growth. Head Neck 1993; 15: 236-240.
16. Moriki T, Takahashi T, Kataoka H, Hiroi M, Yamane T, Hara H. Proliferation marker MIB-1 correlates well with proliferative activity evaluated by BrdU in breast cancer: an immunohistochemical study including correlation with PCNA, p53, c-erbB-2 and estrogen receptor status. Pathology International 1996; 46: 953-961.
17. Zhang Y, Fujita N, Tsuruo T. Caspase-mediated cleavage of p21Waf1/Cip1 converts cancer cells from growth arrest to undergoing apoptosis. Oncogene 1999; 18: 1131-1138.
18. Kayaselcuk F, Zorludemir S, Gumurduhu D, Zeren H, Erman T. PCNA and Ki-67 in central nervous system tumors: correlation with the histological type and grade. J Neuro-Oncol 2002; 57: 115-121.
19. Paiva C, Oshima CT, Lanzoni VP, Forones NM. Apoptosis, PCNA and p53 in hepatocellular carcinoma. Hepato-Gastroenterol 2002; 49: 1058-1061.
20. Zeng WJ, Liu GY, Xu J, Zhou XD, Zhang YE, Zhang N. Pathological characteristics, PCNA labeling index and DNA index in prognostic evaluation of patients with moderately differentiated hepatocellular carcinoma. World J Gastroenterol 2002; 8: 1040-1044.
21. Prochazka M, Gaskins HR, Shultz LD, Leiter EH. The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. Proc Natl Acad Sci USA 1992; 89: 3290-3294.
22. Williams SS, Alosco TR, Croy BA, Bankert RB. The study of human neoplastic disease in severe combined immunodeficient mice. Lab Anim Sci 1993; 43: 139-146.
23. Rheinwald JG, Beckett MA. Defective terminal differentiation in culture as a consistent and selectable character of malignant human keratinocytes. Cell 1980; 22: 629-632.
24. Rheinwald JG, Beckett MA. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas. Cancer Res 1981; 41: 1657-1663.
25. Wu YJ, Rheinwald JG. A new small (40 kd) keratin filament protein made by some cultured human squamous cell carcinomas. Cell 1981; 25: 627-635.
26. Bancroft JD, Cook HC, Stirling RW. Principles of tissue demonstration and routine morphological staining. In: Bancroft JD, Cook HC, Stirling RW, eds. Manual of histological techniques and their diagnostic applications. New York: Churchill Livingstone, 1994: 17-34.
27. Silvestrini G, Mocetti P, Ballanti P, Di Grezia R, Bonucci E. In vivo incidence of apoptosis evaluated with the TdT FragEL DNA fragmentation detection kit in cartilage and bone cells of the rat tibia. Tissue Cell 1998; 30: 627-633.
28. Sciandrello G, Barbaro R, Caradonna F, Barbata G. Early induction of genetic instability and apoptosis by arsenic in cultured Chinese hamster cells. Mutagenesis 2002; 17: 99-103.
29. Fujiwaki R, Hata K, Iida K, Maede Y, Koike M, Miyazaki K. Thymidine phosphorylase expression in progression of cervical cancer: correlation with microvessel count, proliferating cell nuclear antigen, and apoptosis. J Clin Pathol 1999; 52: 598-603.
30. Martins AC, Faria SM, Cologna AJ, Suaid HJ, Tucci S, Jr. Immunoexpression of p53 protein and proliferating cell nuclear antigen in penile carcinoma. J Urol 2002; 167: 89-92.
31. Kindwall EP, Whelan HT. Hyperbaric medicine practice. 2nd ed. Flagstaff: Best publishing company, 1999.
32. Mansfield MJ, Sanders DW, Heimbach RD, Marx RE. Hyperbaric oxygen as an adjunct in the treatment of osteoradionecrosis of the mandible. J Oral Surg 1981; 39: 585-589.
33. Marx RE. Osteoradionecrosis: a new concept of its pathophysiology. J Oral Maxillofac Surg 1983; 41: 283-288.
34. Marx RE, Ames JR. The use of hyperbaric oxygen therapy in bony reconstruction of the irradiated and tissue-deficient patient. J Oral Maxillofac Surg 1982; 40: 412-420.
35. Marx RE, Johnson RP, Kline SN. Prevention of osteoradionecrosis: a randomized prospective clinical trial of hyperbaric oxygen versus penicillin. J Am Dent Asso 1985; 111: 49-54.
36. Moon RE, Feldmeier JJ. Hyperbaric oxygen: an evidence based approach to its application. Undersea Hyperb Med 2002; 29: 1-3.
37. Neovius EB, Lind MG, Lind FG. Hyperbaric oxygen therapy for wound complications after surgery in the irradiated head and neck: a review of the literature and a report of 15 consecutive patients. Head Neck 1997; 19: 315-322.
38. Park NH, Li SL, Xie JF, Cherrick HM. In vitro and animal studies of the role of viruses in oral carcinogenesis. Eur J Cancer 1992; Part B: 145-152.
39. Marx RE, Johnson RP. Relationship of hyperbaric oxygen to oral cancer. In: Davis JC, Hunt TK, eds. Problem wounds: the role of oxygen. New York: Elsevier, 1988: 107-110.
40. Myers JN, Holsinger FC, Bekele BN, Li E, Jasser SA, Killion JJ, Fidler IJ. Targeted molecular therapy for oral cancer with epidermal growth factor receptor blockade: a preliminary report. Arch Otolaryngol - Head Neck Surg 2002; 128: 875-879.
41. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-257.
42. Martin SJ, Lennon SV, Bonham AM, Cotter TG. Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis. J Immunol 1990; 145: 1859-1867.
43. Fawthrop DJ, Boobis AR, Davies DS. Mechanisms of cell death. Arch Toxicol 1991; 65: 437-444.
44. Gu Y, Jow GM, Moulton BC, et al. Apoptosis in decidual tissue regression and reorganization. Endocrinol 1994; 135: 1272-1279.
45. Nagata S, Golstein P. The Fas death factor. Science 1995; 267: 1449-1456.
46. Nagata S. Apoptosis by death factor. Cell 1997; 88: 355-365.
47. Raff M. Cell suicide for beginners. Nature 1998; 396: 119-122.
48. Vaux DL, Korsmeyer SJ. Cell death in development. Cell 1999; 96: 245-254.
49. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980; 284: 555-556.
50. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
51. Haracska L, Unk I, Johnson RE, Phillips BB, Hurwitz J, Prakash L, Prakash S. Stimulation of DNA synthesis activity of human DNA polymerase kappa by PCNA. Mol Cell Biol 2002; 22: 784-791.
52. Griffey SM, Kraegel SA, Madewell BR. Proliferation indices in spontaneous canine lung cancer: proliferating cell nuclear antigen (PCNA), Ki-67 (MIB1) and mitotic counts. J Comp Pathol 1999; 120: 321-332.
53. Niu Y, Liu F, Zhou Z, Wang H. Expression of CD44V6 and PCNA in squamous cell carcinomas. China Med J 2002; 115: 1564-1568.
54. Greene AK, Wiener S, Puder M, et al. Endothelial-directed hepatic regeneration after partial hepatectomy. Ann Surg 2003; 237: 530-535.
55. Kohno Y, Patel V, Kim Y, et al. Apoptosis, proliferation and p12(doc-1) profiles in normal, dysplastic and malignant squamous epithelium of the Syrian hamster cheek pouch model. Oral Oncol 2002; 38: 274-280.